Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George G Klee

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Clinics in Laboratory Medicine|May 26, 2004
Interferences in hormone immunoassaysGeorge G Klee
Clinical Chemistry and Laboratory Medicine|August 26, 2004
Clinical interpretation of reference intervals and reference limits. A plea for assay harmonizationGeorge G Klee
Clinical Chemistry|March 21, 2009
Assay configuration and analytic specificity may have major effects on prediction of clinical outcomes-- implications for reference standardsGeorge G Klee
Clinical Chemistry|March 30, 2010
Establishment of outcome-related analytic performance goalsGeorge G Klee
Clinical Chemistry|April 10, 2010
Harmonization and standardization of thyroid function testsGeorge G Klee
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2014
Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits"Per Hyltoft Petersen, George G Klee
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 2013
Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision LimitsPer Hyltoft Petersen, George G Klee
Archives of Pathology & Laboratory Medicine|February 28, 2004
How sensitive is a prostate-specific antigen measurement? How sensitive does it need to be?Jay L Bock, George G Klee
Archives of Pathology & Laboratory Medicine|March 2, 2005
College of American Pathologists 2003 fresh frozen serum proficiency testing studiesGeorge G Klee, Anthony A Killeen
Archives of Pathology & Laboratory Medicine|September 25, 2004
MUC1 gene-derived glycoprotein assays for monitoring breast cancer (CA 15-3, CA 27.29, BR): are they measuring the same antigen?George G Klee, William E Schreiber
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Clinics in Laboratory Medicine|May 26, 2004
Interferences in hormone immunoassaysGeorge G Klee
Clinical Chemistry and Laboratory Medicine|August 26, 2004
Clinical interpretation of reference intervals and reference limits. A plea for assay harmonizationGeorge G Klee
Clinical Chemistry|March 21, 2009
Assay configuration and analytic specificity may have major effects on prediction of clinical outcomes-- implications for reference standardsGeorge G Klee
Clinical Chemistry|March 30, 2010
Establishment of outcome-related analytic performance goalsGeorge G Klee
Clinical Chemistry|April 10, 2010
Harmonization and standardization of thyroid function testsGeorge G Klee
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2014
Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits"Per Hyltoft Petersen, George G Klee
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 2013
Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision LimitsPer Hyltoft Petersen, George G Klee
Archives of Pathology & Laboratory Medicine|February 28, 2004
How sensitive is a prostate-specific antigen measurement? How sensitive does it need to be?Jay L Bock, George G Klee
Archives of Pathology & Laboratory Medicine|March 2, 2005
College of American Pathologists 2003 fresh frozen serum proficiency testing studiesGeorge G Klee, Anthony A Killeen
Archives of Pathology & Laboratory Medicine|September 25, 2004
MUC1 gene-derived glycoprotein assays for monitoring breast cancer (CA 15-3, CA 27.29, BR): are they measuring the same antigen?George G Klee, William E Schreiber
Pageof 9